The Contraceptive Choice Project
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01986439|
Recruitment Status : Unknown
Verified April 2015 by Jeffrey Peipert, Washington University School of Medicine.
Recruitment status was: Active, not recruiting
First Posted : November 18, 2013
Last Update Posted : April 14, 2015
|Condition or disease|
|Unintended Pregnancy Teen Births Abortion Contraception|
|Study Type :||Observational|
|Actual Enrollment :||9256 participants|
|Official Title:||The Contraceptive Choice Project|
|Study Start Date :||August 2007|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
- Distribution of contraceptive method chosen [ Time Frame: Baseline ]Distribution of methods (%) chosen at baseline enrollment, by method and stratified by Long-Acting Reversible Contraception (LARC: intrauterine device and implant) and non-LARC (depotmedroxyprogesterone acetate (DMPA), oral contraceptive pill (OCP), vaginal ring, transdermal patch).
- Method Continuation [ Time Frame: 6-month, 12 month, 24-month, and 36-month ]% of women using each method at 6, 12-, 24, and 36 months post-enrollment. Hazard rates via survival analysis comparing LARC and non-LARC methods.
- Method Satisfaction [ Time Frame: 12-month, 24-month, 36-month ]% of women very or somewhat satisfied with method at 12, 24, and 36 months of use. Comparison of all methods and stratified by LARC and non-LARC methods.
- Teen Pregnancy Rates [ Time Frame: 1-year, 2-year, 3-year ]Number of pregnancies per participants 15-19 years of age. We will calculate an annual rate for each year from 2007-2013 and also calculate a rate for the cohort followed for 1 year, 2 years, and 3 years.
- Repeat Abortion Rates [ Time Frame: 1-year, 2-year, 3-year ]Number of abortions among participants 15-44 with a history of abortion. We will calculate an annual rate for each year from 2007-2013 and also calculate a rate for the cohort followed for 1 year, 2 years, and 3 years.
- Sexually transmitted infection rates [ Time Frame: Baseline and 12-months ]Baseline prevalence rates (number positive divided by number tested) for chlamydia, gonorrhea, and trichomonas. 1-year incidence rates for the same infections among those who tested at 1-year.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01986439
|United States, Missouri|
|Washington University in St. Louis School of Medicine|
|St. Louis, Missouri, United States, 63110|
|Principal Investigator:||Jeffrey F Peipert, MD PhD||Washington University School of Medicine|